|
US7510845B2
(en)
|
2000-05-04 |
2009-03-31 |
California Institute Of Technology |
Assay employing G protein-coupled receptor expressed in dorsal root ganglia
|
|
US20030092035A1
(en)
|
2000-05-04 |
2003-05-15 |
Anderson David J. |
Pain signaling molecules
|
|
AU2001281936A1
(en)
*
|
2000-06-30 |
2002-01-08 |
Ingenium Pharmaceuticals Ag |
Human g protein-coupled receptor igpcr11, and uses thereof
|
|
EP1614752A3
(en)
*
|
2000-08-22 |
2006-02-15 |
Lexicon Genetics Incorporated |
Novel human 7TM proteins and polynucleotides encoding the same
|
|
AU2001286792A1
(en)
*
|
2000-08-22 |
2002-03-04 |
Lexicon Genetics Incorporated |
Novel human 7TM proteins and polynucleotides encoding the same
|
|
US20020053091A1
(en)
*
|
2000-09-19 |
2002-05-02 |
Ishwar Chandramouliswaran |
Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
|
|
WO2002033079A2
(en)
*
|
2000-10-16 |
2002-04-25 |
Solvay Pharmaceuticals B.V. |
Human g-protein coupled receptor and uses thereof
|
|
GB0025572D0
(en)
*
|
2000-10-18 |
2000-12-06 |
Glaxo Group Ltd |
New polypeptide
|
|
EP1335978A2
(en)
*
|
2000-11-13 |
2003-08-20 |
Bayer Aktiengesellschaft |
Regulation of human extracellular calcium-sensing g protein-coupled receptor
|
|
GB2374596A
(en)
*
|
2000-12-12 |
2002-10-23 |
Glaxo Group Ltd |
An isolated histamine like receptor
|
|
WO2002060948A1
(en)
*
|
2001-01-31 |
2002-08-08 |
Takeda Chemical Industries, Ltd. |
Novel g protein-coupled receptor protein and dna thereof
|
|
WO2002062995A2
(en)
*
|
2001-02-08 |
2002-08-15 |
Bayer Aktiengesellschaft |
Human dorsal root receptor-like g protein-coupled receptor
|
|
CA2443909A1
(en)
*
|
2001-04-11 |
2002-10-24 |
Bristol-Myers Squibb Company |
Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
|
|
FR2823762A1
(en)
*
|
2001-04-24 |
2002-10-25 |
Servier Lab |
New nucleic acid encoding G protein-coupled receptor, useful for identifying specific modulators, potentially useful for treating e.g. diabetes
|
|
US20030143668A1
(en)
*
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
WO2003000893A2
(en)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Nucleic acids encoding g protein-coupled receptors
|
|
US20030096751A1
(en)
*
|
2001-08-20 |
2003-05-22 |
Ramanathan Chandra S. |
G-protein coupled receptor polynucleotides and methods of use thereof
|
|
WO2003066077A2
(en)
*
|
2002-02-06 |
2003-08-14 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
|
|
WO2003087364A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Tanabe Seiyaku Co., Ltd. |
Novel g protein-coupled receptor and its gene
|
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
JPWO2004033687A1
(en)
*
|
2002-10-11 |
2006-02-09 |
アステラス製薬株式会社 |
Methods for screening for renal failure drugs
|
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
|
CA2531073A1
(en)
*
|
2003-06-27 |
2005-02-03 |
Tanox, Inc. |
Human mast cell-expressed membrane protein
|
|
WO2005050220A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 91 (gpr91)
|
|
DK1725249T3
(en)
|
2003-11-06 |
2014-03-17 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugating to ligands.
|
|
WO2005054863A2
(en)
*
|
2003-11-22 |
2005-06-16 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled inwardly rectifying potassium channel (girk 3)
|
|
BRPI0510883B8
(en)
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
drug-antibody conjugate compound, pharmaceutical composition, method of manufacturing a drug-antibody conjugate compound, and uses of a formulation, a drug-antibody conjugate and a chemotherapeutic agent, and a combination
|
|
KR101270829B1
(en)
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
Cystein engineered antibodies and conjugates
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
IN2012DN03025A
(en)
|
2009-09-09 |
2015-07-31 |
Ct Se Llc |
|
|
PE20130214A1
(en)
|
2010-02-23 |
2013-03-11 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS
|
|
US20130028917A1
(en)
|
2010-04-15 |
2013-01-31 |
Spirogen Developments Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2011156328A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
EP2640727B1
(en)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
JP5987053B2
(en)
|
2011-05-12 |
2016-09-06 |
ジェネンテック， インコーポレイテッド |
Multiple reaction monitoring LC-MS / MS method for detecting therapeutic antibodies in animal samples using framework signature peptides
|
|
AU2012322607B2
(en)
|
2011-10-14 |
2017-02-16 |
Genentech, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
MX2015001399A
(en)
|
2012-08-02 |
2015-09-07 |
Genentech Inc |
Anti-etbr antibodies and immunoconjugates.
|
|
US9463251B2
(en)
|
2012-08-02 |
2016-10-11 |
Genentech, Inc. |
Anti-ETBR antibodies and immunoconjugates
|
|
ES2680153T3
(en)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
|
|
EP2906298B1
(en)
|
2012-10-12 |
2018-10-03 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
LT2906253T
(en)
|
2012-10-12 |
2018-10-10 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine - anti-psma antibody conjugates
|
|
PT2906296T
(en)
|
2012-10-12 |
2018-06-01 |
Medimmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ME03486B
(en)
|
2012-10-12 |
2020-01-20 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2887899C
(en)
|
2012-10-12 |
2020-03-31 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
EA031585B1
(en)
|
2012-12-21 |
2019-01-31 |
Медимьюн Лимитед |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN105209077B
(en)
|
2013-03-13 |
2019-06-11 |
麦迪穆有限责任公司 |
Pyrrolobenzodiazepines Zhuo and its conjugate
|
|
AR096287A1
(en)
|
2013-03-13 |
2015-12-23 |
Spirogen Sàrl |
PIRROLOBENZODIACEPINS AND CONJUGATES
|
|
CA2904044C
(en)
|
2013-03-13 |
2020-03-31 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US10442836B2
(en)
|
2013-08-12 |
2019-10-15 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3054986B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX2016007826A
(en)
|
2013-12-16 |
2017-03-31 |
Genentech Inc |
Peptidomimetic compounds and antibody-drug conjugates thereof.
|
|
MX2016007578A
(en)
|
2013-12-16 |
2016-10-03 |
Genentech Inc |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
|
|
BR112016012410A2
(en)
|
2013-12-16 |
2017-09-26 |
Genentech Inc |
drug-antibody conjugate, drug-antibody conjugate, non-peptide compound, method of treating human disease and pharmaceutical composition
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2016040825A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
CN107108724A
(en)
|
2014-09-12 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
Cysteine engineered antibody and conjugate
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
SG11201702079UA
(en)
|
2014-09-17 |
2017-04-27 |
Genentech Inc |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
|
CA2968447A1
(en)
|
2014-11-25 |
2016-06-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
|
|
CA2969689A1
(en)
|
2014-12-03 |
2016-06-09 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
MA43345A
(en)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
|
MA43354A
(en)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
|
|
MA45326A
(en)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
EP3433621A1
(en)
|
2016-03-25 |
2019-01-30 |
H. Hoffnabb-La Roche Ag |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
ES2858151T3
(en)
|
2016-05-20 |
2021-09-29 |
Hoffmann La Roche |
PROTAC-Antibody Conjugates and Procedures for Use
|
|
CN109313200B
(en)
|
2016-05-27 |
2022-10-04 |
豪夫迈·罗氏有限公司 |
Bioanalytical methods for characterizing site-specific antibody-drug conjugates
|
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
|
JP7093767B2
(en)
|
2016-08-11 |
2022-06-30 |
ジェネンテック， インコーポレイテッド |
Pyrrolobenzodiazepine prodrug and its antibody conjugate
|
|
JP7050770B2
(en)
|
2016-10-05 |
2022-04-08 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
Method for preparing antibody drug conjugate
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
KR20200032243A
(en)
|
2017-02-08 |
2020-03-25 |
에이디씨 테라퓨틱스 에스에이 |
Pyrrolobenzodiazepine-antibody conjugates
|
|
PT3612537T
(en)
|
2017-04-18 |
2022-08-29 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
EP3612234B1
(en)
|
2017-04-20 |
2024-03-13 |
ADC Therapeutics SA |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
UA127900C2
(en)
|
2017-06-14 |
2024-02-07 |
Ейдісі Терапьютікс Са |
Dosage regimes for the administration of an anti-cd19 adc
|
|
DK3668874T3
(en)
|
2017-08-18 |
2022-02-14 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
RU2020113749A
(en)
|
2017-09-20 |
2021-10-20 |
пиЭйч ФАРМА Ко., ЛТД. |
ANALOGUES OF THAILANSTATIN
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
|
TW202037381A
(en)
|
2018-10-24 |
2020-10-16 |
瑞士商赫孚孟拉羅股份公司 |
Conjugated chemical inducers of degradation and methods of use
|
|
WO2020123275A1
(en)
|
2018-12-10 |
2020-06-18 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|